Company Profile

BioLife Solutions Stock Price, News & Analysis

Ticker:
BLFS
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

33.93 USD (+0.38%)

Close

Last updated: August 6, 2026

1.34B USD

Market cap

Why the stock is moving

As of Aug 6, 2026, BLFS closed up 0.38% at $33.93. No new same-company headline was identified in the current news window.

Company overview

Business overview

BioLife Solutions is a life-sciences tools company focused on biopreservation, storage, and cryogenic logistics for cell and gene therapy workflows. Its products support the manufacturing and handling side of advanced therapies.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, BioLife sits in biotech infrastructure.

Business Model Characteristics

Revenue comes from consumables, storage systems, and workflow tools used by advanced-therapy developers.

Position Within the Biotechnology Landscape

BioLife is an enabling platform name whose value tracks cell and gene therapy infrastructure spending.

Future catalysts

BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering. The company can improve quickly if cell therapy activity really normalizes.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of BioLife Solutions (BLFS)?

    BioLife Solutions (BLFS) most recently closed at 33.93 USD, a +0.38% move versus the previous session.

    What is the market cap of BioLife Solutions (BLFS)?

    BioLife Solutions currently has a market capitalization of 1.34B USD on BioPharmSignal.

    What does BioLife Solutions do?

    BioLife Solutions is a life-sciences tools company focused on biopreservation, storage, and cryogenic logistics for cell and gene therapy workflows. Its products support the manufacturing and handling side of advanced therapies.

    On which exchange is BLFS stock listed?

    BioLife Solutions (BLFS) is associated with NASDAQ, United States, Biopharma.

    What is BioLife?

    BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering.

    Which conditions is BioLife Solutions targeting with BioLife?

    BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering.

    How does BioLife Solutions describe recent progress with BioLife?

    BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering.

    What is Solutions?

    BioLife Solutions is a life-sciences tools company focused on biopreservation, storage, and cryogenic logistics for cell and gene therapy workflows.